Drug Type Small molecule drug |
Synonyms (E)-2-[3-(1-pyrrolidinyl)-1-p-toluenepropenyl]pyridine, trans-1-(2-pyridyl)-3-pyrrolidino-1-p-tolylprop-1-ene, trans-1-(4-methylphenyl)-1-(2-pyridyl)-3-pyrrolidinoprop-1-ene + [9] |
Target |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (01 Jul 1983), |
Regulation- |
Molecular FormulaC19H25ClN2O |
InChIKeyCUZMOIXUFHOLLN-UMVVUDSKSA-N |
CAS Registry6138-79-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01782 | Triprolidine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypersensitivity | US | 01 Jul 1983 |